| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Oct 2, 2025 | Forte Biosciences, Inc. | CFO | Sell | 45.0 | -134 | -0.42% | ✗ | $1.9K |
| Jul 1, 2025 | Jul 3, 2025 | Forte Biosciences, Inc. | CFO | Sell | 45.0 | -134 | -0.42% | ✗ | $1.7K |
| Apr 1, 2025 | Apr 2, 2025 | Forte Biosciences, Inc. | CFO | Sell | 45.0 | -154 | -0.49% | ✗ | $1.1K |
| Jan 1, 2025 | Jan 2, 2025 | Forte Biosciences, Inc. | CFO | Sell | 45.0 | -154 | -0.49% | ✗ | $3.5K |
| Nov 21, 2024 | Nov 22, 2024 | Forte Biosciences, Inc. | CFO | Buy | 95.0 | +22,514 | 272.50% | ✗ | $125K |
| Oct 1, 2024 | Oct 2, 2024 | Forte Biosciences, Inc. | CFO | Sell | 27.5 | -133 | -1.58% | ✗ | $686.3 |
| Jul 1, 2024 | Jul 3, 2024 | Forte Biosciences, Inc. | CFO | Sell | 27.5 | -3,345 | -1.64% | ✗ | $1.8K |
| Apr 1, 2024 | Apr 2, 2024 | Forte Biosciences, Inc. | CFO | Sell | 27.5 | -3,345 | -1.69% | ✗ | $2.4K |
| Jan 1, 2024 | Jan 3, 2024 | Forte Biosciences, Inc. | CFO | Sell | 27.5 | -3,841 | -2.00% | ✗ | $3.2K |
| Oct 1, 2023 | Oct 3, 2023 | Forte Biosciences, Inc. | CFO | Sell | 27.5 | -3,241 | -1.74% | ✗ | $2.1K |
| Jul 1, 2023 | Jul 5, 2023 | Forte Biosciences, Inc. | CFO | Sell | 27.5 | -3,241 | -11.57% | ✗ | $3.4K |
| Apr 1, 2023 | Apr 4, 2023 | Forte Biosciences, Inc. | CFO | Sell | 27.5 | -3,241 | -14.82% | ✗ | $3.3K |
| Sep 7, 2021 | Sep 7, 2021 | Forte Biosciences, Inc. | CFO | Sell | 22.5 | -25,000 | -69.32% | ✗ | $106.1K |
| Jun 26, 2020 | Jun 30, 2020 | Forte Biosciences, Inc. | CFO | Buy | 95.0 | +6,700 | 22.82% | ✗ | $96.4K |
| May 22, 2018 | May 24, 2018 | Krystal Biotech, Inc. | CFO | Buy | 91.3 | +2,800 | 100.00% | ✗ | $30.1K |